Skip to main navigation Skip to search Skip to main content

Multimodality approach to mediastinal staging in non-small cell lung cancer. Faults and benefits of PET-CT: a randomised trial

  • Barbara M Fischer
  • , Jann Mortensen
  • , Hanne Hansen
  • , Peter Vilmann
  • , Søren Larsen
  • , Annika Loft
  • , Anne-Katrine Bertelsen
  • , Jesper Ravn
  • , Paul Clementsen
  • , Asbjørn Høegholm
  • , Klaus Richter Larsen
  • , Asger Dirksen
  • , Birgit G Skov
  • , Mark Krasnik
  • , Liselotte Højgaard
  • , Ulrik Lassen
  • , Søren Schytt Larsen
  • , Annika Loft Jakobsen
  • , Anne Kiil Berthelsen

    Research output: Contribution to journal › Journal article › Research › peer-review

    Abstract

    Correct mediastinal staging is a cornerstone in the treatment of patients with non-small cell lung cancer. A large range of methods is available for this purpose, making the process of adequate staging complex. The objective of this study was to describe faults and benefits of positron emission tomography (PET)-CT in multimodality mediastinal staging.
    Original languageEnglish
    JournalThorax
    Volume66
    Issue number4
    Pages (from-to)294-300
    Number of pages7
    ISSN0040-6376
    DOIs
    Publication statusPublished - 1 Apr 2011

    Cite this